The Cooperative Agreement announced in this FOA represents the continuation and further refinement as well as expansion of well-established collaborations between WHO and FDA, through OIP, in support of data-driven and science-based public health, science-based and research strategies and approaches

credit: Wikimedia Commons

How's Your Community Doing?
Check Out it's
Community Vital Signs

that align well with FDA domestic and global goals.

This cooperative agreement is expected to contribute to the knowledge base of the current regulatory efforts in support of food and medical products safety and quality globally and address specific challenges and fill gaps in the global efforts to ensure said safety and quality of such products.

Relevant strategies include:
1) developing global norms and standards; 2) articulating evidence-based and science-based policy options, including those relating to regulatory systems performance; and 3) providing technical support to national regulatory authorities and governments through systems strengthening, research, public health and scientific efforts.